R. J. Packer

1.4k total citations
8 papers, 967 citations indexed

About

R. J. Packer is a scholar working on Genetics, Neurology and Epidemiology. According to data from OpenAlex, R. J. Packer has authored 8 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Neurology and 3 papers in Epidemiology. Recurrent topics in R. J. Packer's work include Glioma Diagnosis and Treatment (6 papers), Neuroblastoma Research and Treatments (3 papers) and Meningioma and schwannoma management (3 papers). R. J. Packer is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Neuroblastoma Research and Treatments (3 papers) and Meningioma and schwannoma management (3 papers). R. J. Packer collaborates with scholars based in United States, Australia and Canada. R. J. Packer's co-authors include Gregory H. Reaman, Jeffrey C. Allen, Peter C. Phillips∥, Russ Geyer, Jonathan L. Finlay, Michael N. Needle, H. Stacy Nicholson, Joann L. Ater, Elizabeth Kurczynski and Robert Listernick and has published in prestigious journals such as Neurology, Journal of neurosurgery and American Journal of Ophthalmology.

In The Last Decade

R. J. Packer

8 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. J. Packer United States 6 701 612 355 166 151 8 967
Trent R. Hummel United States 15 449 0.6× 331 0.5× 219 0.6× 199 1.2× 97 0.6× 37 759
Rolf‐D. Kortmann Germany 9 339 0.5× 658 1.1× 139 0.4× 187 1.1× 227 1.5× 10 810
F. Pichon France 12 371 0.5× 514 0.8× 159 0.4× 347 2.1× 263 1.7× 27 921
Arnault Tauziède‐Espariat France 15 320 0.5× 520 0.8× 231 0.7× 203 1.2× 187 1.2× 83 804
Thorsten Pietsch Germany 11 251 0.4× 614 1.0× 207 0.6× 167 1.0× 252 1.7× 14 825
George C. Bobustuc United States 13 365 0.5× 221 0.4× 204 0.6× 193 1.2× 219 1.5× 24 983
Anu Banerjee United States 16 355 0.5× 597 1.0× 150 0.4× 282 1.7× 152 1.0× 32 956
Bernadine Donahue United States 12 239 0.3× 507 0.8× 178 0.5× 91 0.5× 249 1.6× 19 635
Amedeo A. Azizi Austria 17 335 0.5× 435 0.7× 180 0.5× 284 1.7× 224 1.5× 76 907
Jeffrey Krischer United States 13 356 0.5× 618 1.0× 106 0.3× 288 1.7× 231 1.5× 27 860

Countries citing papers authored by R. J. Packer

Since Specialization
Citations

This map shows the geographic impact of R. J. Packer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. J. Packer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. J. Packer more than expected).

Fields of papers citing papers by R. J. Packer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. J. Packer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. J. Packer. The network helps show where R. J. Packer may publish in the future.

Co-authorship network of co-authors of R. J. Packer

This figure shows the co-authorship network connecting the top 25 collaborators of R. J. Packer. A scholar is included among the top collaborators of R. J. Packer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. J. Packer. R. J. Packer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Fisher, MJ, Michael J. Loguidice, David H. Gutmann, et al.. (2012). Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro-Oncology. 14(6). 790–797. 203 indexed citations
2.
Haas‐Kogan, Daphne A., Tina Young Poussaint, Mehmet Koçak, et al.. (2011). Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas. Neuro-Oncology. 13(3). 298–306. 66 indexed citations
3.
Fisher, MJ, David H. Gutmann, Robert Listernick, et al.. (2010). NEUROFIBROMATOSIS TYPE 1 ASSOCIATED OPTIC GLIOMA VISUAL OUTCOMES FOLLOWING CHEMOTHERAPY: AN INTERNATIONAL MULTI-CENTER RETROSPECTIVE ANALYSIS. UCL Discovery (University College London). 12(6). 5 indexed citations
4.
Listernick, Robert, et al.. (1997). Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic pathway glioma task force.. American Journal of Ophthalmology. 124(2). 274–274. 70 indexed citations
5.
Packer, R. J., Joann L. Ater, Jeffrey C. Allen, et al.. (1997). Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. Journal of neurosurgery. 86(5). 747–754. 426 indexed citations
6.
Packer, R. J., Joann L. Ater, Jeffrey C. Allen, et al.. (1997). Carboplatin and Vincristine Chemotherapy for Children with Newly Diagnosed Progressive Low-Grade Gliomas. Journal of Neuro-Ophthalmology. 17(4). 289–289. 1 indexed citations
7.
Packer, R. J., L. Sutton, Joel W. Goldwein, et al.. (1991). Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. Journal of neurosurgery. 74(3). 433–440. 176 indexed citations
8.
Cohen, Bruce H., et al.. (1989). Gadolinium‐DTPA‐enhanced magnetic resonance imaging in childhood brain tumors. Neurology. 39(9). 1178–1178. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026